Neoatricon (Dopamine Hydrochloride)

Dopamine Hydrochloride, the active ingredient in Neoatricon, is a vasopressor presented as an injectable solution for intravenous use. It is employed to raise blood pressure and improve cardiac output in patients with hypotension, cardiogenic shock, acute heart failure, or renal perfusion deficits.

GNH USA supplies Neoatricon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to healthcare institutions across multiple regions. Delivery is coordinated with local import requirements to ensure timely availability for critical care settings.

Neoatricon (dopamine hydrochloride) acts on dopaminergic, beta‑1 adrenergic and alpha‑adrenergic pathways to support cardiovascular function.

- Hypotension: Increases systemic vascular resistance and cardiac output to raise blood pressure. - Cardiogenic shock: Enhances myocardial contractility and perfusion to stabilize hemodynamics. - Acute heart failure: Improves stroke volume and organ perfusion during decompensation. - Renal perfusion support: Augments renal blood flow, aiding diuresis and kidney function in critical illness.

Common Side Effects: - Tachycardia: Elevated heart rate due to beta‑1 stimulation. - Nausea or vomiting: Gastrointestinal irritation. - Headache: Resulting from rapid hemodynamic changes. - Anxiety or restlessness: Central nervous system activation. - Arrhythmia: Premature beats or ectopic rhythms. - Local infusion site irritation: Redness or mild pain.

Serious or Rare Side Effects: - Myocardial ischemia: Reduced coronary perfusion from excessive demand. - Severe hypertension: Over‑activation of alpha receptors. - Tissue necrosis at infusion site: Extravasation injury. - Life‑threatening arrhythmias: Ventricular tachycardia or fibrillation. - Anaphylactic reaction: Rare hypersensitivity. - Pulmonary edema: Fluid overload in susceptible patients.

Neoatricon requires careful monitoring and individualized dosing. - Dose titration: Adjust infusion rate based on real‑time hemodynamic response. - Renal impairment: Monitor renal function and modify therapy as needed. - Cardiac arrhythmias: Use cautiously in patients with pre‑existing rhythm disorders. - Pregnancy: Administer only if potential benefits outweigh uncertain risks. - Drug interactions: Review concomitant vasoactive agents for additive effects. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Dopamine may interact with several cardiovascular agents.

Major Interactions (Avoid): - MAO inhibitors: Risk of hypertensive crisis. - Beta‑blockers: May blunt desired cardiac response. - Vasopressin: Additive vasoconstriction can cause severe hypertension. - Tricyclic antidepressants: Enhanced catecholamine effects increase cardiovascular stress.

Moderate Interactions (Monitor Closely): - Diuretics: May amplify hypotensive response when dopamine dose is low. - ACE inhibitors: Potential for unpredictable blood pressure fluctuations.